GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells
Salinomycin (Sal) is a potent inhibitor with effective anti-breast cancer properties in clinical therapy. The occurrence of various side effect of Sal greatly limits its application. The epidermal growth factor receptor (EGFR) family is a family of receptors highly expressed in most breast cancer ce...
Main Authors: | Kaichun Li MD, Liying Pang MS, Xiaorong Pan MS, Shaonan Fan MS, Xinxin Wang MS, Qiaoyun Wang MS, Ping Dai MS, Wei Gao MD, Jie Gao PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338211004954 |
Similar Items
-
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
by: Zeng Xiaowei, et al.
Published: (2011-01-01) -
Pharmaceutical Properties of Nanoparticulate Formulation Composed of TPGS and PLGA for Controlled Delivery of Anticancer Drug
by: Mu, L., et al.
Published: (2003) -
Apigenin Loaded Lipoid–PLGA–TPGS Nanoparticles for Colon Cancer Therapy: Characterization, Sustained Release, Cytotoxicity, and Apoptosis Pathways
by: Mohamed A. Alfaleh, et al.
Published: (2022-08-01) -
TPGS-b-PBAE Copolymer-Based Polyplex Nanoparticles for Gene Delivery and Transfection In Vivo and In Vitro
by: Jiahui Ding, et al.
Published: (2024-01-01) -
Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
by: Desta Assefa MS, et al.
Published: (2023-12-01)